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semiconductor sequencing  
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Heidi K. Mjoseng1, Richard Clark2, Audrey Coutts2, Lee Murphy2 & Richard R. Meehan1
Modification of DNA resulting in 5-methylcytosine (5 mC) or 5-hydroxymethylcytosine (5hmC) 
has been shown to influence the local chromatin environment and affect transcription. Although 
recent advances in next generation sequencing technology allow researchers to map epigenetic 
modifications across the genome, such experiments are often time-consuming and cost prohibitive. 
Here we present a rapid and cost effective method of generating genome wide DNA modification 
maps utilising commercially available semiconductor based technology (DNA immunoprecipitation 
semiconductor sequencing; “DIP-SC-seq”) on the Ion Proton sequencer. Focussing on the 5hmC mark 
we demonstrate, by directly comparing with alternative sequencing strategies, that this platform can 
successfully generate genome wide 5hmC patterns from as little as 500 ng of genomic DNA in less 
than 4 days. Such a method can therefore facilitate the rapid generation of multiple genome wide 
epigenetic datasets.
The advent of next-generation sequencing (NGS) technology has resulted in a tremendous acceleration 
in the rates at which large sets of transcriptional, genetic and epigenetic data can be generated and 
analysed; impacting on a wide range of scientific disciplines1,2. Today’s sequencing based experiments 
typically generate more data than alternative methods such as microarray based assays; allowing the 
researcher to carry out high resolution analyses such as quantification of both transcriptional activ-
ity (RNA sequencing: RNAseq) and epigenetic modification patterns (DNA modification sequencing; 
“DIP-seq” and chromatin immunoprecipitation sequencing; “ChIP-seq”3–5. However the cost of gener-
ating replicates, compared to array based methods, can be steep. At present, Illumina based sequencing 
technologies (“Mi-seq” and “Hi-seq” DNA sequencers) are most frequently applied for the majority of 
genome wide studies. In 2010, Life Technologies developed a DNA sequencer which uses the principles 
of ion semiconductor sequencing6,7. In short, the DNA of interest is hybridised to a microwell plate (or 
“P1 chip”) prior to the addition of a specific deoxyribonucleotide triphosphate (dNTPs) in the presence 
of DNA polymerase. The reaction chamber is flooded with a single species of dNTPs. If the introduced 
dNTP is complimentary to the leading base on the template strand it is incorporated into a growing 
strand, which causes the release of a hydrogen ion, which triggers an ion-sensitive field-effect transistor 
(ISFET) sensor and the reaction continues (Supplemental Figure 1). Multiple dNTP molecules will be 
1MRC Human Genetics Unit at the Institute of Genetics and Molecular Medicine at the University of Edinburgh, 
Crewe Road, Edinburgh, EH4 2XU, UK. 2Wellcome Trust Clinical Research Facility, University of Edinburgh, Western 
General Hospital, Crewe Road, Edinburgh, UK. Correspondence and requests for materials should be addressed to 
J.P.T. (email: John.Thomson@igmm.ed.ac.uk) or R.R.M. (email: Richard.Meehan@igmm.ed.ac.uk)
Received: 13 December 2014
accepted: 02 March 2015
Published: 18 May 2015
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 5:09778 | DOi: 10.1038/srep09778
incorporated in a single cycle if runs of a particular dNTP are present leading to a corresponding number 
of released hydrogens and a proportionally higher electronic signal.
It was recently shown that “first generation” Ion Torrent sequencers were capable of accurately map-
ping the abundant histone H3 lysine 4 tri-methylation (H3K4me3) modification across the genome8. 
However this first generation technology is only able to sequence ~6 million reads in a single run – 
rendering it unable to reach the required read depth to sequence the far less discrete DNA modification 
patterns. With the recent development of a “second generation” semiconductor based sequencer (named 
the “Ion Proton sequencer”), which is capable of sequencing between 80–100 million reads per run, 
researchers are now able to explore the use of this relatively cost-effective and rapid sequencer for DNA 
modification based genome wide studies. In addition, semiconductor sequencing has the advantage of 
being able to sequence longer DNA fragments than alternative platforms (typically ~120 bp–150 bp (or 
greater) in length compared to Illumina 50 bp or 100 bp read lengths; Table 1) which increases the map-
ping efficiency greatly. Here we outline a method that utilises this commercially available semiconduc-
tor sequencing technology to generate genome wide patterns of DNA modifications following antibody 
immunoprecipitation; although this method will also work for 5hmC libraries generated by alternative 
enrichment strategies4,9. We focus in particular on profiling of the recently characterised and low abun-
dant 5-hydroxymethylation (5hmC) mark, which constitutes between 0.1–7% of modified cytosine in 
non-CNS mouse tissues, the pattern of which is strongly perturbed in many cancers10–14. We have also 
successfully profiled the 5 mC mark in both tissue and cell lines using the same protocol (JT, unpublished 
data).
Figure 1. A flow-chart for the DNA immunoprecipitation semiconductor sequencing (DIP-SC-seq) protocol. 
Major steps in the DIP-SC-seq protocol are shown which can be broken into four stages. Step i is to enrich 
the DNA fragments of interest through antibody based pull downs. Step ii is low level whole genome 
amplification to generate double stranded DNA. Step iii is the preparation of sequencing libraries prior to 
sequencing on the semiconductor itself. And finally step iv is bioinformatic processing and normalisation. 
Overall it is possible to complete the entire protocol in less than 4 days.
Ion Proton P1 Illumina Hiseq 2000
start up sequencer costs ~$250,000 (USD) ~ $650,000 (USD)
ave read length 125bp 35bp (single end)
100bp x2  
(paired end)
sequencing adapter cost
LOW (added post 
enrichment to ng 
DNA)
HIGHER (added pre 
enrichment to μ g of 
DNA)
HIGHER (added pre 
enrichment to μ g of 
DNA)
library prep and sequencing 
cost comparable comparable comparable
total GB data per run 6-10Gb 26-35Gb 200Gb
time to sequence 4 hrs 36 hrs 192 hrs
maximum GB per hour 2.5 Gb/hr 0.97 Gb/hr 1.04 Gb/hr
Time to 100 Gb 40 hrs 103 hrs 96.1 hrs
Table 1.   
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Results
Experimental design overview. Currently there are a host of methods to study the genome wide 
distributions of the 5hmC mark both at single base resolution15,16 and following enrichment for the 
5hmC modification4,13,17–20. Due to the high cost of the former (a great degree of sequencing is required 
to generate sufficient coverage for such experiments), enrichment based assays (such as “affinity” enrich-
ment or antibody based purification methods) are most routinely applied to study the distribution of 
5hmC throughout the genome. Although these two techniques result in the generation of highly similar 
genome wide 5hmC patterns, a small number difference have been noted – particularly at CG poor 
loci and simple tandem repeats9,21. Due to the relative robustness of the protocol, high specificity of the 
antibody and overall quality of the resulting data17,22,23 we have adapted standard antibody enrichment 
protocols (hydroxymethyl DNA immunoproceipitation; hmeDIP) to generate genome wide datasets for 
5hmC using a semiconductor sequencing approach which is both rapid, requiring under 4 hours to run 
and cost effective relative to alternative next generation sequencing strategies (table 1).
The first phase of the hydroxymethyl DNA immunoprecipitation and semiconductor sequencing 
(“hmeDIP-SC-seq”) protocol relies on the fragmentation of high quality genomic DNA to generate a 
range of fragments 100–500 bp long, the majority of which are around 300 bp in length (Fig.  1). The 
next stage focusses on the enrichment of the fragmented DNA fragments which contain the epigenetic 
Figure 2. Whole genome amplification (WGA) as a method to generate double stranded DNA following 
DNA immunoprecipitation. (a) Schematic of the steps during the WGA. Red = WGA adapter sequences 
(b). Quantitative PCR (qPCR) analysis of several loci prior to WGA (post hmeDIP: light grey) as well as 
following WGA (dark grey) reveals little to no bias is introduced by the WGA. Analysis of the signals from 
the hmeDIP-SC-seq over these same regions highlights the retention of the patterns following sequencing 
(red bars). Loci were selected from previous work: 5hmC –ve = little/no 5hmC, 5hmC +ve = moderate/
high 5hmC. Light grey bars: pre-amplified IP DNA, dark grey bars: post WGA DNA, red bars: normalised 
signals over locus used for qPCR taken from hmeDIP-SC-seq liver A dataset. qPCR data plotted against the 
primary y-axis, hmeDIP SC-seq data plotted against secondary y-axis (c). Glu-RES-qPCR results of three 
loci reveal quantitative information on 5hmC levels at a given site, confirming that pre and post WGA 
samples in fig. 2b reflect the expected 5hmC patterns. Tan: unmodified CpG, pink: methylated CpG, blue: 
hydroxymethylated CpG. (d) Examples of good and poor read length distributions following SC-seq. The 
majority of successfully sequenced DNA fragments should be >100 bp with a mean around 125–150 bp. (e) 
Plot of mapping efficiency vs read length. Reads less than 50 bp should be excluded due to poor mapping 
accuracy.
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mark of interest (in this case 5hmC) using a highly specific antibody (for full protocol see17). It is also 
important that a reference input sample (10% of the total starting material) is removed prior to the 
enrichment steps and processed in parallel through the subsequent. This will allow the researcher to 
determine true enrichment over the background sequencing “noise”. In total these steps can take up to 
6 hours to complete (Fig. 1).
One notable downside of using the hmeDIP protocol is that the DNA must be denatured in order 
to facilitate efficient binding of the antibody. This results in an enriched library of single stranded DNA 
fragments. However in order to add specific adapter sequences to the ends of the DNA, the DNA must 
be double stranded. For this reason sequencing adaptors have been traditionally added to the genomic 
DNA prior to the enrichment steps, which is an expensive and somewhat technically challenging process. 
In the protocols outlined here we do not add the adapter sequences until after the enrichment stages. 
This is achieved by converting the single stranded DNA fragments enriched by hmeDIP into double 
stranded fragments by carrying out a low number of whole genome amplification (WGA) cycles using 
a commercially available method optimised for next generational sequencing (Sigma Aldrich enhanced 
amplification kit) (Fig. 2a). As this amplification requires the addition of its own adapter sequences, these 
Figure 3. HmeDIP-SC-seq derived 5hmC data is comparable to published datasets using alternative 
profiling methodologies. (a) Scatter plots for 500,000 random 200 bp windows to plot biological replicate 
liver 5hmC levels for published hmeDIP tiled microarrays (i) or between hmeDIP-SC-seq (ii) datasets. R2 
values are shown in each plot. For i, plots refer to log2 scores whilst ii refers to normalised average reads in 
a given 200 bp window. (b) Pearson’s correlation matrix with hierarchical clustering for replicate hmeDIP-
SC-seq, input SC seq, hmeDIP-Hiseq, published affinity 5hmC Illumina Hiseq and 5hmC tiled microarray 
datasets. (c) Visual example of 5hmC patterns in the average input normalised hmeDIP-SC-seq (red), input 
normalised hmeDIP-Hiseq (green), published affinity Hiseq (blue) and published hmeDIP microarray 
datasets (gold) over a 2.5 Mb region on chromosome 7 (chr7:85,183,840–87,720,240). For a comparison, 
average input SC-seq data is shown in grey below. On the right, comparative 5hmC profiles are shown for 
hmeDIP-SC-seq and 5hmC affinity Hi-seq datasets over select loci (Cdkn1a and Klf3).
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are specifically cleaved off following amplification in order to increase the read quality from subsequent 
sequencing runs. Through comparison of our pre- and post- whole genome amplified material by qPCR 
over positive and negative control regions for 5hmC candidate loci (fig.  3b), which we independently 
validate using a glucosyl-sensitive restriction enzyme digestion assay (gRES-qPCR: see supplementary 
information) we do not find a significant degree of amplification bias introduced through such steps 
(Fig. 2b,c).
Following validation by quantitative PCR (qPCR) over known positive and negative control loci 
(Fig.  2b), the next stage is to prepare libraries from the input and enriched (or immunoprecipitated; 
“IP”) samples by the addition of specific barcoded adapter sequences (see online methods; ~6 hours), 
prior to template preparation (~7 hours) and sequencing on Ion P1 chips (~4 hours, (see online methods 
for more information)). Finally the reads are then mapped to the reference genome and basic bioinfor-
matic normalisation and processing applied to generate genome wide patterns of the DNA modification 
of interest. If desired, it is possible to sequence a matched input for each IP on a single P1 chip (using 
specific barcoded sequencing adapters) allowing for an internal normalisation much like microarray 
technology does24. In addition to revealing enrichment values over the background sequencing noise, 
such normalisation will allow the direct comparison of datasets from karyotypically different sources. 
The resulting datasets can therefore either represent total reads across the genome (IP only) or total reads 
relative to input across the genome (a ratio of the IP reads vs the Input reads).
Considerations to note following semiconductor sequencing. The amount of coverage (or depth) 
required for a sequencing experiment will be critical for the overall cost of the project. Traditionally this 
value refers to the number of times a nucleotide is read, versus the entire genome length. However 
for epigenetic based assays such as for 5hmC, true coverage values can be hard to achieve due to the 
fact that only select sites (certain CpG dinucleotides) are marked by the modification. For a single 
hmeDIP-SC-seq experiment (i.e. hmeDIP and matched input samples both sequenced on a single P1 
microwell), between 70 and 80 million high quality reads are typically achieved (~35–40 million per IP 
or input sample. Table 1). We find that this number of reads, combined with the fact that the read lengths 
are frequently 120–150 bp long, results in comparable coverage values to similar published 5hmC and 
5 mC DIP Illumina sequenced datasets25 (Supplementary Table 1).
Not only does the long read length increase the potential depth of the experiment but also results in 
high mapping efficiencies (typically >90% of reads mapped to the reference genome). To achieve optimal 
sequencing it is therefore important to check the size range of the sequenced DNA fragments. This will 
depend heavily on i) how well the initial gDNA was sheared prior to the DIP, ii) on the size selection 
imposed following the addition of the specific sequencing adapters and iii) on the quality of the DNA 
sequence (Fig. 2d). If the DNA sequence is of poor quality or contains left over WGA adapter sequence 
at its ends, the sequence will fall below the required QC cut-offs and the bases will not be included. As 
such these poor quality or repetitive bases will be removed resulting in smaller recorded sequences than 
expected (typically less than 50 bp in length). Additionally, degraded DNA fragments or residual unin-
corporated WGA adapter sequences will also be found in the pool of sequences less than 50 bp if these 
are not properly removed in the size selection step. Sequences less than 50 bp in length exhibit lower 
mapping accuracy scores than the longer fragments (Fig. 2e).
Proof of principle: analysis of semiconductor derived hmeDIP-seq genome wide mouse liver 
5hmC patterns. To test the utility of the Ion Proton as a method of generating genome wide DNA 
modification patterns we chose to characterise the low abundant 5hmC modification in mouse liver 
DNA; a modification and a tissue which are suitable for this type of analysis9,23,26–28. We directly com-
pared the genome wide sequencing patterns for mouse liver hmeDIP libraries sequenced either on a 
single P1 Ion proton microwell or Illumina Hiseq 2000 lane (50 bp single end reads) as well as comparing 
to a published mouse liver 5hmC affinity enriched Hiseq dataset29 in which 5hmC marked DNA is first 
glucosylated and then captured using modified biotin beads4. In addition, we also carried out compar-
ative analysis against tiled microarray datasets which were generated through hmeDIP enrichment9. To 
test for reproducibility of the semiconductor sequencing we carried out biological replicate runs on two 
mouse livers. To allow for direct comparisons of the datasets and to smooth the data we carried out 
sliding window analysis (see methods) with a window length of 200 bp.
Comparisons of the overall correlations between the probe values generated on biological replicate 
mouse livers on the tiled microarrays as well as the semiconductor reveals that both are similarly repro-
ducible (R2 values of 0.5587 for the hmeDIP microarrays and 0.6599 for the hmeDIP-SC-seq runs with 
Pearson’s correlations of 0.6712 and 0.6327 respectively; Fig. 3a,b). Analysis of the overall Pearson’s cor-
relations between all of the datasets reveals that genome wide liver 5hmC profiles by hmeDIP-SC-seq 
are similar to those sequenced on the Hiseq – both following hmeDIP and affinity enrichment strategies 
(Fig. 3b). In fact the hmeDIP enriched datasets clustered closer together than the chemical affinity method, 
arguing that enrichment method supersedes sequencing strategy as a means of generating comparable 
5hmC patterns. As expected the microarrays cluster separately from the genome wide sequencing data-
sets. Although the two input (genomic sheared liver DNA) lanes were highly correlated with each other 
(Pearson’s correlation of 0.82) they displayed no correlation to the hmeDIP-SC-seq datasets (Pearson’s 
correlations < 0.07). Such a result reveals that the 5hmC patterns generated by the hmeDIP-SC-seq 
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protocol are not strongly influenced by an inherent background sequencing bias. Visualisation of the 
datasets reinforces the use of the Ion torrent Proton technology as a suitable sequencer to map epigenetic 
marks; with similar patterns observed between the average hmeDIP-SC-seq, hmeDIP-Hiseq, Affinity 
Hiseq and average hmeDIP microarrays are shown in Fig. 3c.
It has been widely reported that the majority of 5hmC resides in the bodies of genes and pro-
moter proximal regions of the genome whilst being depleted directly over the transcriptional start sites 
(TSS; for a review see13). Focusing on genic regions, we find that the 5hmC patterns generated though 
hmeDIP-SC-seq are in agreement with these findings and to patterns generated by hmeDIP-Hiseq and 
affinity Hiseq (Fig. 4a). Although there is a slight difference in the levels of 5hmC at the start of the gene 
body these differences appear to be related to the enrichment technique employed as they are specific 
to the affinity enriched 5hmC dataset. We then compare global distributions of the 5hmC modification 
through hmeDIP-SC-seq, hmeDIP-Hiseq and affinity-Hiseq routes by calling “peaks” of enrichment in 
the sequencing datasets (see online methods) which results in a binary output of the most strongly 5hmC 
modified regions. Mapping of these peaks to one of 5 compartments of the genome (promoter core, pro-
moter proximal, promoter distal, intra-genic and inter-genic; see online methods) reveal a very similar 
genomic distribution of 5hmC marked regions in all three datasets (Fig. 4b).
In addition to comparing to alternative sequencing strategies, we demonstrate the utility of 
hmeDIP-SC-seq as a tool for epigenetic analysis through two independent systems (Fig.  5). Firstly 
through the analysis of epigenetic toxicological insult in the mouse liver following long term drug expo-
sure, and secondly in cell culture assays and the analysis of epigenetic differences which arise during 
reprogramming to induced pluripotent stem cells (IPSCs). Using promoter specific microarrays we 
have previously shown that exposure to the non-genotoxic carcinogen, phenobarbital (PB), results in 
an altered 5hmC landscape in the mouse liver23,27,28. In particular, the gene Cyp2b10, is both strongly 
induced to express and undergoes epigenetic change following PB exposure. Through hmeDIP-SC-seq 
Figure 4. HmeDIP-SC-seq derived 5hmC patterns closely resemble those derived through sequencing on 
the Illumina Hiseq platform. (a) The average 5hmC patterns across genic portions of the genome are plotted 
for replicate hmeDIP-SC-seq runs (red and pink) alongside those for hmeDIP-Hiseq (green) and affinity-
Hiseq (blue). The average number of reads in a 200 bp window are then calculated across each gene before 
averaging across 22,093 genes loci. Genic loci are extended 25% upstream and downstream of each region to 
analyse the surrounding environment. (b) The genomic distributions of 5hmC enriched windows (“peaks”. 
see supplementary information) in the hmeDIP-SC-seq, hmeDIP-Hiseq and published affinity Hi-seq 
datasets were compared by mapping to one of the five indicated regions in the genome. Percentage of total 
peaks mapping to each locus are shown.
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we are able to validate these promoter specific changes as well as report on a strong genic elevation 
of 5hmC in the drug exposed animal; revealing a novel use for semiconductor sequencing in toxicity 
testing (Fig. 5a). Finally it was recently shown that 5hmC patterns may be used to identify cells which 
have been successfully reprogrammed into IPCs30. With this in mind we carried out hmeDIP-SC-seq on 
mouse IPSCs as well as the embryonic fibroblasts (MEFs) from which they were derived. Analysis of the 
resulting 5hmC patterns over select loci identified as being expressed exclusively in the MEFs or IPSCs31 
reveals that such loci also have strong differences in their 5hmC patterns; once more highlighting the 
utility of hmeDIP-SC-seq as an analytical tool (Fig. 5b).
Discussion
An overwhelming degree of evidence, most recently fuelled by advances in NGS technology, suggests that 
changes to epigenetic patterns can reflect the underlying gene expression patterns of a given cell and as 
such are fundamental to the overall cellular identity of the cell (for a review see)32,33. In addition, the epig-
enome can become perturbed in response to environmental change and toxicological insult23 as well as 
altered in a range of developmental disorders and diseases such as in cancer progression34. The advent of 
next generation sequencing technology has allowed researchers to study these epigenomes in more detail 
and attempt to better understand the epigenetic and molecular events which dynamically change during 
disease progression. However this approach has several drawbacks; largely the high costs associated with 
library preparation and subsequent sequencing, as well as relatively lengthy sequencing times. The high 
start-up costs of purchasing such hardware means that many researchers instead turn to biotech partners 
to sequence their DNA rather than attempt to do it in house, further adding to processing times. With this 
in mind we have optimised a simple protocol to utilise the Ion Torrent Proton semiconductor sequencer 
(Life tech) to generate genome wide profiles of epigenetic modifications. Focussing on the 5hmC DNA 
modification we have developed a protocol based on antibody enrichment followed by semiconductor 
sequencing (hydroxymethyl DNA immunoprecipitation semiconductor sequencing; “hmeDIP-SC-seq”) 
which returns reproducible patterns of the 5hmC mark that are comparable to datasets derived through 
Illumina based sequencing methods as well as high resolution microarray approaches. This case study 
investigating 5hmC profiles in liver DNA reveals the utility of the Ion Proton sequencer as an accurate, 
reproducible, rapid and cost effective strategy for DIP-seq and ChIP-seq projects.
Figure 5. Examples of the utility of DIP-SC-seq. (a) 5hmC patterns generated by hmeDIP-SC-seq 
reflect toxicological insult over the Cyp2b10 locus. Genic 5hmC patterns are elevated following 91 days 
phenobarbital (PB) exposure (pink) compared to the control liver 5hmC (blue). This reflects a strong 
elevation in gene expression from this locus (data not shown). Box on the left highlights the promoter 
region of the Cyp2b10 gene and compares hmeDIP-SC-seq patterns to published 5hmC promoter 
microarrays. Regions which gain 5hmC upon drug expose are highlighted pink, regions which lose 5hmC 
are highlighted blue. (b) 5hmC patterns generated by hmeDIP-SC-seq can be used to track epigenetic 
changes which occur during reprogramming in cultured cells. Analysis of the 5hmC patterns over several 
candidate loci reveal IPSC specific loci (i), MEF specific loci (ii) as well as those which share a common 
5hmC pattern (iii).
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Methods
Full methods and any associated references are available in supplementary information.
Overview of hmeDIP-SC-seq. >500 ng of genomic DNA is sheared to ~300 bp long fragments 
prior to immunoprecipitation (IP) with antibodies against 5hmC (Active motif rabbit polyclonal against 
hydroxymethylation cat#39769). For full protocols see17. 10% of the input is also taken prior to immu-
noprecipitation. In all stages DNA was purified using DNA Clean & Concentrator™ (Zymo Research).
The IP and input samples undergo 10 cycles of whole genome amplification following associated pro-
tocols (Sigma-Aldrich SeqPlex DNA Amplification Kit). Sequencing libraries are made from 100 ng of 
DNA for each sample, using the Ion XpressPlus Fragment Library Kit (life Technologies™). The DNA 
was end repaired, purified and then ligated to Ion-compatible barcoded adapters (Ion Xpress™ Barcode 
Adapters 1–96: Life Technologies™), followed by nick-repair to complete the linkage between adapters 
and DNA inserts. The adapter-ligated library was then amplified (10 cycles) and finally size-selected 
using two rounds of AMPure XP bead capture to size‐select fragments approximately 100–250 bp in 
length. Samples were then pooled in a 1:1 ratio and sequenced on a single Ion Proton P1 microwell chip 
(Life Technologies™). Sequence reads were mapped to the reference genome using the supplied TMAP 
mapping software and the resulting BAM file processed for downstream data analysis.
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